Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


Rapid Biologics Development to Maximize your Speed to Clinic

Product Image
Product Description

Whether you are using a Catalent GPEx® technology-based cell line or a client-derived cell line, we can design a process for your project that can be easily transferred to our production plant. All operations from cell line development through production of preclinical and/or clinical (Phase I/II) API can be performed in a single facility with a dedicated project manager – thus ensuring better continuity and reliability. Backed by experts in the fields of molecular biology, cell line development, process development, biopharmaceutical manufacturing, and quality systems, we are able to streamline processes, and enhance performance, and speed through to clinical production.

Catalent Services

• Generation of master and working cell banks
• Cell line stability studies
• Upstream process development in shake flask and bioreactor systems (2L - 10L)
• Downstream process development at the milligram to 100s gram scale
• Scale down and non-cGMP production (up to 100L) in disposable and stainless bioreactors
• cGMP manufacturing of Phase I / Phase II material in product-dedicated suites using stirred tank bioreactors at the 200L scale

Product Rapid Biologics Development to Maximize your Speed to Clinic
Company Catalent Pharma Solutions
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Catalent Pharma Solutions
Sedge Close, Headway, Great Oakley Corby, Northamptonshire NN18 8HS, England

Tel: 44 (0) 1536 461146
Fax: 44 (0) 1536 461011
Email: info@catalent.com



Scientific News
Advanced Lymphoma in Remission After T-Cell Therapy
63% of trial participants who recieved two-drug combination chemo plus intermediate dose of engineered T cells went into complete remission.
New Treatment for Immune Cancers
Clinical trial shows new drug holds promise for treating advanced mastocytosis.
Sickle Cell Gene Therapy Passes Test
Researchers found a precision-engineered gene therapy virus reduced sickle-induced red-cell damage in mice with sickle cell disease.
Opening Door to Oesophageal Cancer Targeted Treatments
Scientists have discovered that oesophageal cancer can be classified into three different subtypes.
Inovio Launches Zika Vaccine Trial
Inovio launches Zika vaccine trial in midst of Puerto Rico epidemic to explore early signals of vaccine efficacy.
Vitamin C May Boost Leukemia Treatment
Studies show that supplementing an epigenetic cancer drug with vitamin C enhanced the drug's effectiveness.
New Hope for Zika Treatment Found in Large-Scale Screen of Existing Drugs
Johns Hopkins researchers join collaborative group to screen 6,000 existing drugs in hopes of finding treatments for Zika Virus infection
FINCH Filgotinib Phase 3 Program Initiated
Galapagos NV reports the initiation of the FINCH global Phase 3 program in rheumatoid arthritis patient populations.
Stem Cell Therapy Heals Injured Mouse Brain
A team of researchers has developed a therapeutic technique that dramatically increases the production of nerve cells in mice with stroke-induced brain damage.
Zika Vaccine Testing in Humans
The NAAID has initiated a clinical trail of a vaccine candidate for the prevention of the Zika virus infection.
Scroll Up
Scroll Down

SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!